Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Motherwort injection for residual fetal membranes after vaginal delivery
ChiCTR1800019664Phase 4Completed
- Sponsor
- West China Second University Hospital
- Start
- Aug 2017
- Countries
- 1
01
Overview
Phase 4, open-label trial of Motherwort in retained placenta and subinvolution of the uterus (2 arms), sponsored by West China Second University Hospital. Primary endpoints: Lochia status, Uterine three-diameter measurements and 5 more. Started Aug 2017; status: completed.
02
Drugs
Motherwort
03
Conditions
retained placentasubinvolution of the uterus
Beyond the preview
Go deeper on ChiCTR1800019664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019664.